BURST DIAGNOSTICS LLC

FORT COLLINS, CO · Founded 2022 · Medtech · Private

Point-of-care diagnostic platform for rapid, quantitative lab-quality clinical tests

Claim this profile

Follows are private to you and power your alerts

Updated · burst-dx.com

Sector
Medtech
Headquarters
FORT COLLINS, CO
Founded
2022
Latest Form D
$2.4M, Jan 2024
Total capital
$3M
Federal grants
$581K
2 awards · 2023–2025
Rank in peer group#156 of 445
Private capital raised
$2.4M
1 Form D · last Jan 2024
33 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
0
3 pending

Capital timeline

202320242025FEDERAL ↑EQUITY ↓Cumulative $3M$280K$301K1st Form D$2.4M
202320242025FEDERAL ↑EQUITY ↓Cumulative $3M$280K$301K1st Form D$2.4M

Latest events

  • Federal grantHealth and Human S · Phase I · Multiplexed Hormone Test for Personalizing Menopause Treatment$301K
  • Private capital raisedForm D · SEC · 1st filing$2.4M
  • Federal grantHealth and Human S · Phase I · Strep-CaDI: A fast, accurate, and sensitive point-of-care test for Group A Streptococcus$280K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Federal first

6months

from BURST DIAGNOSTICS LLC’s first federal award to its first private round.

First federal award · Jul 2023
Health and Human S · $280K
First Form D · Jan 2024
$2.4M · 1st Form D
Awards before first raise
1 award

An association in public records, not a cause or a prediction.

Standing among 445 peers

Line = median

Medtech · Device

  • Federal grants#156 · top 35%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • Cathy PettiDirectorNamed in SEC Form D filings
  • Charles HenryExecutive Officer, DirectorNamed in SEC Form D filings
  • Mary GunnDirectorNamed in SEC Form D filings
  • Tim JonesDirectorNamed in SEC Form D filings
  • Xi Yu (Larry) JiaDirectorNamed in SEC Form D filings

What it has protected

USPTO · 0 granted of 3
  • PendingDevice For Allowing Pressurization Of Fluid In A Microfluidic Diagnostic DeviceUSPTOApplication 18289707
  • PendingChemiluminescence Microfluidic Immunoassay Device And Methods Of Use ThereofUSPTOApplication PCTUS2024022736
  • PendingDevice For Allowing Pressurization Of Fluid In A Microfluidic Diagnostic DeviceUSPTOApplication PCTUS2022028800
  • Strive Tech Inc.Similar federal contract value in Medtech · null in contracts
  • Definitive Biotechnologies LLCSimilar federal contract value in Medtech · null in contracts
  • RETHAM TECHNOLOGIES, INC.Similar federal contract value in Medtech · null in contracts
  • ONTERA INC.Similar federal contract value in Medtech · null in contracts
  • FirstVitals Inc.Similar federal contract value in Medtech · null in contracts
  • DIADEM US, INC.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .